CK2 Inhibitor

CK2 Inhibitors (25):

Cat. No.	Product Name	Effect	Purity

HY-50855

Silmitasertib	Inhibitor	99.92%
Silmitasertib (CX-4945) is an orally bioavailable, highly selective and potent CK2 inhibitor, with IC₅₀ values of 1 nM against CK2α and CK2α'.

HY-14393

Emodin	Inhibitor	99.20%
Emodin (Frangula emodin), an anthraquinone derivative, is an anti-SARS-CoV compound.

HY-B0183

Ellagic acid	Inhibitor	≥98.0%
Ellagic acid is a natural antioxidant, and acts as a potent and ATP-competitive CK2 inhibitor, with an IC₅₀ of 40 nM and a K_i of 20 nM.

HY-14394

TBB	Inhibitor	99.31%
TBB is a cell-permeable and ATP-competitive CK2 inhibitor with an IC₅₀ of 0.15 μM for rat liver CK2.

HY-50855B

Silmitasertib sodium salt	Inhibitor	99.91%
Silmitasertib sodium salt is an orally bioavailable, highly selective and potent CK2 inhibitor, with IC₅₀ values of 1 nM against CK2α and CK2α'.

HY-15535

DMAT	Inhibitor	98.09%
DMAT is a potent and specific CK2 inhibitor with an IC₅₀ value of 130 nM.

HY-15479

TTP 22	Inhibitor	98.03%
TTP 22 is a potent CK2 inhibitor, with an IC₅₀ of 100 nM and a K_i of 40 nM.

HY-119751

Hematein	Inhibitor
Hematein is a oxidation product of hematoxylin acted as a dye.

HY-129571

BioE-1115	Inhibitor	98.08%
BioE-1115 is a highly selective and potent PAS kinase (PASK) inhibitor with an IC₅₀ of ~4 nM.

HY-139004

SGC-CK2-1	Inhibitor	99.41%
SGC-CK2-1 is a highly potent, ATP-competitive, and cell-active CK2 chemical probe with exclusive selectivity for both human CK2 isoforms, with IC₅₀s of 36 and 16 nM for CK2α and CK2α′respectively in the nanoBRET assay.

HY-135906

CK2/ERK8-IN-1	Inhibitor	≥99.0%
CK2/ERK8-IN-1 is a dual casein kinase 2 (CK2) (K_i of 0.25 µM) and ERK8 (MAPK15, ERK7) inhibitor with IC₅₀s of 0.50 μM.

HY-108606

PI-828	Inhibitor	99.09%
PI-828 is a dual PI3K and casein kinase 2 (CK2) inhibitor with IC₅₀s of 173 nM, 149 nM, and 1127 nM for p110α, CK2, and CK2α2 in lipid kinase assay, respectively.

HY-110052

TBCA	Inhibitor	99.60%
TBCA is a highly selective CK2 (casein kinase II) inhibitor with an IC₅₀ of 110 nM and a K_i of 77 nM.

HY-125957

A-3 hydrochloride	Inhibitor	99.67%
A-3 hydrochloride is a potent, cell-permeable, reversible, ATP-competitive non-selective antagonist of various kinases.

HY-132175

CK2 inhibitor 2	Inhibitor	98.12%
CK2 inhibitor 2 is a potent, selective and orally active inhibitor of CK2, with an IC₅₀ of 0.66 nM.

HY-10108A

LY294002 hydrochloride	Inhibitor
LY294002 hydrochloride is a potent and broad-spectrum PI3K inhibitor, with IC₅₀ values of 0.5, 0.57, and 0.97 μM for P110α, P110δ and P110β, respectively.

HY-145260

BRD4/CK2-IN-1	Inhibitor	98.62%
BRD4/CK2-IN-1 is the first highly effective and oral active dual-target inhibitor of BRD4/CK2 (bromodomain-containing protein 4/casein kinase 2), with IC₅₀s of 180 nM and 230 nM for BRD4 and CK2, respectively.

HY-151382

CK2-IN-3	Inhibitor
CK2-IN-3 is a selective and potent CK2 inhibitor (K_d: 12 nM), with IC₅₀ values of 1.51 μM (CK2α) and 7.64 μM (CK2α’).

HY-B0183A

Ellagic acid (hydrate)	Inhibitor
Ellagic acid hydrate is a natural antioxidant, and acts as a potent and ATP-competitive CK2 inhibitor, with an IC₅₀ of 40 nM and a K_i of 20 nM.

HY-135816

CK2/PIM1-IN-1	Inhibitor
CK2/PIM1-IN-1 is an inhibitor of CK2 and PIM1, with IC₅₀s of 3.787 μM and 4.327 μM for CK2 and PIM1, respectively.

Name
Email *

	Sorry, but the email address you supplied was invalid.